Overview

Inhaled Beclomethasone to Prevent Chronic Lung Disease

Status:
Completed
Trial end date:
1999-04-01
Target enrollment:
Participant gender:
Summary
To test if inhaled glucocorticoids, early in the course of respiratory failure in premature infants, permit normal lung growth and differentiation, thus preventing development of bronchopulmonary dysplasia.
Phase:
Phase 3
Details
Lead Sponsor:
National Heart, Lung, and Blood Institute (NHLBI)
Treatments:
Beclomethasone